Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2007

Nieto M, Finn S, Loda M, Hahn WC. Prostate cancer: Re-focusing on androgen receptor signaling. Int J Biochem Cell Biol. 2007;39(9):1562-8.

Berlingieri MT, Pallante P, Sboner A, Barbareschi M, Bianco M, Ferraro A, et al. UbcH10 is overexpressed in malignant breast carcinomas. Eur J Cancer. 2007;43(18):2729-35.

Tu JJ, Rohan S, Kao J, Kitabayashi N, Mathew S, Chen Y-. Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues. Mod Pathol. 2007;20(9):921-8.

Nassar A, Cohen C, Siddiqui MT. Utility of millipore filter and cell block in thyroid needle aspirates: which method is superior? Diagn Cytopathol. 2007;35(1):34-8.

Gardenghi S, Marongiu MF, Ramos P, Guy E, Breda L, Chadburn A, et al. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood. 2007;109(11):5027-35.

Jean RD, Eble JN, Zhang S, Cheng L. Pure cartilaginous teratoma of the testis: an immunohistochemistry and fluorescence in situ hybridisation study. J Clin Pathol. 2007;60(10):1166-8.

Y Wang L, Lee JW, Kui JS, Chadburn A, Cross NC, Knowles DM, et al. Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals. Acta Haematol. 2007;118(4):209-14.

Hittelman A, Sridharan S, Roy R, Fridlyand J, Loda M, Collins C, et al. Evaluation of whole genome amplification protocols for array and oligonucleotide CGH. Diagn Mol Pathol. 2007;16(4):198-206.

Niesvizky R, Naib T, Christos PJ, Jayabalan D, Furst JR, Jalbrzikowski J, et al. Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy. Br J Haematol. 2007;138(5):640-3.

Lamant L, de Reyniès A, Duplantier M-, Rickman DS, Sabourdy F, Giuriato S, et al. Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes. Blood. 2007;109(5):2156-64.